Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
NRG Oncology
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Children's Oncology Group
University of Iowa
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Mayo Clinic
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
University of Maryland, Baltimore
Emory University
Mayo Clinic
Centre Paul Strauss
Memorial Sloan Kettering Cancer Center
University of Utah
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
NRG Oncology
NYU Langone Health
University of Kentucky
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
University of Washington
City of Hope Medical Center
National Cancer Institute (NCI)
Sun Yat-sen University
NRG Oncology
Children's Oncology Group
NRG Oncology
Mayo Clinic
Mayo Clinic
NRG Oncology